Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study-Reference-Cited by-同舟云学术

Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study

Published:2017-07-24 Issue:1 Volume:16 Page:
ISSN:1476-0711
Container-title:Annals of Clinical Microbiology and Antimicrobials
language:en
Short-container-title:Ann Clin Microbiol Antimicrob

Author:

Su Ting-Yi,Ye Jung-Jr,Yang Chien-Chang,Huang Ching-Tai,Chia Ju-Hsin,Lee Ming-Hsun

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12941-017-0227-8.pdf

Reference25 articles.

1. Eliopoulos GM, Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003;36:1433–7.

2. Gaynes RP, Edwards JR. The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States. Clin Infect Dis. 2008;47:927–30.

3. Hirsch EB, Cottreau JM, Chang K-T, Caeiro J-P, Johnson ML, Tam VH. A model to predict mortality following Pseudomonas aeruginosa bacteremia. Diagn Microbiol Infect Dis. 2012;72:97–102.

4. DeFife R, Scheetz MH, Feinglass JM, Postelnick MJ, Scarsi KK. Effect of differences in MIC values on clinical outcomes in patients with bloodstream infections caused by gram-negative organisms treated with levofloxacin. Antimicrob Agents Chemother. 2009;53:1074–9.

5. Tam VH, Gamez EA, Weston JS, Gerard LN, LaRocco MT, Caeiro JP, et al. Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin–tazobactam: implications on the appropriateness of the resistance breakpoint. Clin Infect Dis. 2008;46:862–7.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Outcomes for Carbapenem-Resistant and Cephalosporin-Susceptible Pseudomonas aeruginosa Pneumonia;Annals of Pharmacotherapy;2023-09-26

2. The role of cascade reporting integrated with breakpoint to minimum inhibitory concentration quotient (minimum inhibitory concentration therapeutic index) and minimum inhibitory concentration guiding table on clinical microbiology reporting of culture-proven bloodstream infections;Journal of Current Research in Scientific Medicine;2023-09-05

3. An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by Pseudomonas aeruginosa and Acinetobacter baumannii in Critically Ill Adult Patients;Antibiotics;2021-12-28

4. Cephalosporins Interfere With Quorum Sensing and Improve the Ability of Caenorhabditis elegans to Survive Pseudomonas aeruginosa Infection;Frontiers in Microbiology;2021-01-28

5. An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa;Journal of Antimicrobial Chemotherapy;2020-12-17